Home > Press Releases > Genomic Collaboration Market

Genomic Collaboration Market Likely to Surpass USD 10.5 Billion by 2035

Report Code: HC-77412  |  Published in: Aug 2026, By MarketGenics  |  Number of pages: 280
Get PDF
Buy

Global Genomic Collaboration Market Forecast 2035:

According to the report, the global genomic collaboration market is likely to grow from USD 4.7 Billion in 2025 to USD 10.5 Billion in 2035 at a highest CAGR of 8.4% during the time period. The genomic collaborative market is growing as precision medicine, next-generation sequencing, AI, and multiomics are becoming more intertwined in both the health-care and life-science research sectors. The increasing need for individual diagnosis and personalized therapies has spurred pharmaceutical firms, diagnostic services, sequencing companies, research institutes and healthcare systems to merge complementary skills and data.

The rapid expansion of high throughput sequencing and bioinformatics is facilitating ever faster and more scalable genomic analysis, and AI is enhancing the ability to interpret highly complex genomic data and to further support the discovery of biomarkers, disease characterization and therapeutic development. Genomics is more and more being integrated with transcriptomics, proteomics, metabolomics and clinical data, driving the need for interoperability, shared data, and specialized analytical tools.

Population-scale genomic projects and the increasing focus on precision medicine using AI are driving the integration of different sectors, with organizations looking for various streams of data and powerful computational resources to translate the genomic data into clinical use. Strategic partnerships are increasing and commercial opportunities are expanding throughout the genomic value chain with the convergence of genomics, AI, multiomics, and precision medicine.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global Genomic Collaboration Market

The growing demand for easy sharing of genomic data across different sequencing platforms, laboratories, electronic health records, research databases, and clinical systems is driving further collaboration needs. Standardized data structures, genomic APIs, metadata frameworks, and interoperable workflows allow organizations to integrate data sets together and leverage genomic outcomes across platforms.

Sequencing platform variations, file formats for genomic data, different types of annotations, metadata formats, and data interpretation pipelines can present technical challenges for collaborative data integration. The cost of implementation and the time required to collaborate may be high due to organizations requiring extra infrastructure and validation of their data to allow for harmonisation for joint analysis.

The growing emphasis on standardized and interoperable healthcare data creates an opportunity for genomic companies to develop platforms that connect sequencing, laboratory, clinical, and research datasets. Vendors and healthcare providers can partner with technology companies, laboratories and research groups to provide services for data exchange, harmonization and interpretation of genomic data.

Regional Analysis of Global Genomic Collaboration Market

  • North America dominates the genomic collaboration market because it is home to a large number of academic research centers, pharmaceutical companies, and genomic technologies developers. The region also has well-established commercialization channels from genomic research through drug discovery and to the health care system.
  • Asia Pacific is witnessing strong growth due to the efforts of countries to enable population genomics, precision medicine, and genomic research infrastructure, as well as the issues of ethnic diversity in the global datasets. Singapore's National Precision Medicine program is pushing for the incorporation of whole genome sequencing into the nation's healthcare system and regional efforts are fostering inter-regional genomic research.
  • Europe is experiencing strong growth through coordinated genomic-data infrastructure, cross-border research programs, and government-backed precision-medicine initiatives. The European 1+ Million Genomes initiative is advancing the secure sharing of data across borders, shared sequencing-quality specifications, and unified genomic and clinical databases.

Key players in the global genomic collaboration market include prominent companies such as Broad Institute, DNAnexus, Foundation Medicine, Inc., Genestack Ltd, Genomenon, Inc., Genomics England, Genomics4RD, Illumina, QIAGEN, Regeneron Genetics Center, Sema4 (GeneDx), Seven Bridges Genomics, Sophia Genetics SA, Thermo Fisher Scientific, Other Key Players.

The global genomic collaboration market has been segmented as follows:

Global Genomic Collaboration Market Analysis, by Collaboration Type

  • Research Collaborations
    • Academic–Academic Collaborations
    • Academic–Industry Collaborations
    • Industry–Industry Collaborations
    • Government–Academic Collaborations
    • Government–Industry Collaborations
    • Public–Private Partnerships
    • International Genomics Consortia
  • Data Sharing Collaborations
  • Clinical Research Collaborations
  • Drug Discovery Collaborations
  • Biobank Collaborations
  • Population Genomics Collaborations
  • Precision Medicine Collaborations
  • AI-Driven Genomics Collaborations

Global Genomic Collaboration Market Analysis, by Collaboration Model

  • Consortium-Based Collaboration
  • Strategic Alliance
  • Joint Venture
  • Research Partnership
  • Licensing & Technology Transfer
  • Co-development Agreement
  • Contract Research Collaboration
  • Public Health Genomics Partnership

Global Genomic Collaboration Market Analysis, by Genomic Data Type

  • Whole Genome Sequencing (WGS) Data
  • Whole Exome Sequencing (WES) Data
  • Targeted Gene Panel Data
  • Microarray/SNP Data
  • Transcriptomic (RNA-Seq) Data
  • Epigenomic Data
  • Multi-Omics Integrated Data
  • Other Technologies

Global Genomic Collaboration Market Analysis, by Platform

  • Genomic Data Platforms
  • Cloud Collaboration Platforms
  • Bioinformatics Platforms
  • Laboratory Information Management Systems
  • Clinical Decision Support Platforms
  • AI Analytics Platforms
  • Collaborative Research Portals

Global Genomic Collaboration Market Analysis, by Deployment Mode

  • Cloud-Based
  • On-Premise
  • Hybrid

Global Genomic Collaboration Market Analysis, by Organization Size

  • Large Enterprises
  • Mid-sized Organizations
  • Small & Medium Enterprises
  • Start-ups

Global Genomic Collaboration Market Analysis, by Application

  • Drug Discovery & Target Identification
  • Precision/Personalized Medicine
  • Population Genomics & Biobanking
  • Rare Disease Research
  • Oncology Genomics
  • Agrigenomics & Crop Improvement
  • Infectious Disease Genomic Surveillance
  • Clinical Diagnostics & Reporting
  • Other Applications

Global Genomic Collaboration Market Analysis, by End-Users

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutions
  • Hospitals & Diagnostic Laboratories
  • Government & Public Health Agencies
  • Contract Research Organizations (CROs)
  • Agricultural & Agrotech Companies
  • Other End-Users

Global Genomic Collaboration Market Analysis, by Region

  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact US

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

 

Table of Contents

  • 1. Research Methodology and Assumptions
    • 1.1. Definitions
    • 1.2. Research Design and Approach
    • 1.3. Data Collection Methods
    • 1.4. Base Estimates and Calculations
    • 1.5. Forecasting Models
      • 1.5.1. Key Forecast Factors & Impact Analysis
    • 1.6. Secondary Research
      • 1.6.1. Open Sources
      • 1.6.2. Paid Databases
      • 1.6.3. Associations
    • 1.7. Primary Research
      • 1.7.1. Primary Sources
      • 1.7.2. Primary Interviews with Stakeholders across Ecosystem
  • 2. Executive Summary
    • 2.1. Global Genomic Collaboration Market Outlook
      • 2.1.1. Genomic Collaboration Market Size Value (US$ Bn), and Forecasts, 2021-2035
      • 2.1.2. Compounded Annual Growth Rate Analysis
      • 2.1.3. Growth Opportunity Analysis
      • 2.1.4. Segmental Share Analysis
      • 2.1.5. Geographical Share Analysis
    • 2.2. Market Analysis and Facts
    • 2.3. Supply-Demand Analysis
    • 2.4. Competitive Benchmarking
    • 2.5. Go-to- Market Strategy
      • 2.5.1. Customer/ End-use Industry Assessment
      • 2.5.2. Growth Opportunity Data, 2026-2035
        • 2.5.2.1. Regional Data
        • 2.5.2.2. Country Data
        • 2.5.2.3. Segmental Data
      • 2.5.3. Identification of Potential Market Spaces
      • 2.5.4. GAP Analysis
      • 2.5.5. Potential Attractive Price Points
      • 2.5.6. Prevailing Market Risks & Challenges
      • 2.5.7. Preferred Sales & Marketing Strategies
      • 2.5.8. Key Recommendations and Analysis
      • 2.5.9. A Way Forward
  • 3. Industry Data and Premium Insights
    • 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
      • 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
      • 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
      • 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
    • 3.2. Supplier Customer Data
    • 3.3. Technology Roadmap and Developments
  • 4. Market Overview
    • 4.1. Market Dynamics
      • 4.1.1. Drivers
        • 4.1.1.1. Increasing genomic data sharing and cross-institutional research collaborations
        • 4.1.1.2. Rising adoption of precision medicine and genomic diagnostics
        • 4.1.1.3. Growing investments in genomics, AI, and advanced sequencing technologies
      • 4.1.2. Restraints
        • 4.1.2.1. Data privacy, security, and ownership concerns
        • 4.1.2.2. High costs and interoperability challenges associated with genomic data integration
    • 4.2. Key Trend Analysis
    • 4.3. Regulatory Framework
      • 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
      • 4.3.2. Tariffs and Standards
      • 4.3.3. Impact Analysis of Regulations on the Market
    • 4.4. Ecosystem Analysis
    • 4.5. Porter’s Five Forces Analysis
    • 4.6. PESTEL Analysis
    • 4.7. Global Genomic Collaboration Market Demand
      • 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
      • 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
        • 4.7.2.1. Y-o-Y Growth Trends
        • 4.7.2.2. Absolute $ Opportunity Assessment
  • 5. Competition Landscape
    • 5.1. Competition structure
      • 5.1.1. Fragmented v/s consolidated
    • 5.2. Company Share Analysis, 2025
      • 5.2.1. Global Company Market Share
      • 5.2.2. By Region
        • 5.2.2.1. North America
        • 5.2.2.2. Europe
        • 5.2.2.3. Asia Pacific
        • 5.2.2.4. Middle East
        • 5.2.2.5. Africa
        • 5.2.2.6. South America
    • 5.3. Product Comparison Matrix
      • 5.3.1. Specifications
      • 5.3.2. Market Positioning
      • 5.3.3. Pricing
  • 6. Global Genomic Collaboration Market Analysis, by Collaboration Type
    • 6.1. Key Segment Analysis
    • 6.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Collaboration Type, 2021-2035
      • 6.2.1. Research Collaborations
        • 6.2.1.1. Academic–Academic Collaborations
        • 6.2.1.2. Academic–Industry Collaborations
        • 6.2.1.3. Industry–Industry Collaborations
        • 6.2.1.4. Government–Academic Collaborations
        • 6.2.1.5. Government–Industry Collaborations
        • 6.2.1.6. Public–Private Partnerships
        • 6.2.1.7. International Genomics Consortia
      • 6.2.2. Data Sharing Collaborations
      • 6.2.3. Clinical Research Collaborations
      • 6.2.4. Drug Discovery Collaborations
      • 6.2.5. Biobank Collaborations
      • 6.2.6. Population Genomics Collaborations
      • 6.2.7. Precision Medicine Collaborations
      • 6.2.8. AI-Driven Genomics Collaborations
  • 7. Global Genomic Collaboration Market Analysis, by Collaboration Model
    • 7.1. Key Segment Analysis
    • 7.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Collaboration Model, 2021-2035
      • 7.2.1. Consortium-Based Collaboration
      • 7.2.2. Strategic Alliance
      • 7.2.3. Joint Venture
      • 7.2.4. Research Partnership
      • 7.2.5. Licensing & Technology Transfer
      • 7.2.6. Co-development Agreement
      • 7.2.7. Contract Research Collaboration
      • 7.2.8. Public Health Genomics Partnership
  • 8. Global Genomic Collaboration Market Analysis, by Genomic Data Type
    • 8.1. Key Segment Analysis
    • 8.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Genomic Data Type, 2021-2035
      • 8.2.1. Whole Genome Sequencing (WGS) Data
      • 8.2.2. Whole Exome Sequencing (WES) Data
      • 8.2.3. Targeted Gene Panel Data
      • 8.2.4. Microarray/SNP Data
      • 8.2.5. Transcriptomic (RNA-Seq) Data
      • 8.2.6. Epigenomic Data
      • 8.2.7. Multi-Omics Integrated Data
      • 8.2.8. Other Technologies
  • 9. Global Genomic Collaboration Market Analysis, by Platform
    • 9.1. Key Segment Analysis
    • 9.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Platform, 2021-2035
      • 9.2.1. Genomic Data Platforms
      • 9.2.2. Cloud Collaboration Platforms
      • 9.2.3. Bioinformatics Platforms
      • 9.2.4. Laboratory Information Management Systems
      • 9.2.5. Clinical Decision Support Platforms
      • 9.2.6. AI Analytics Platforms
      • 9.2.7. Collaborative Research Portals
  • 10. Global Genomic Collaboration Market Analysis and Forecasts, by Deployment Mode
    • 10.1. Key Findings
    • 10.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Deployment Mode, 2021-2035
      • 10.2.1. Cloud-Based
      • 10.2.2. On-Premise
      • 10.2.3. Hybrid
  • 11. Global Genomic Collaboration Market Analysis and Forecasts, by Organization Size
    • 11.1. Key Findings
    • 11.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Organization Size, 2021-2035
      • 11.2.1. Large Enterprises
      • 11.2.2. Mid-sized Organizations
      • 11.2.3. Small & Medium Enterprises
      • 11.2.4. Start-ups
  • 12. Global Genomic Collaboration Market Analysis and Forecasts, by Application
    • 12.1. Key Findings
    • 12.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
      • 12.2.1. Drug Discovery & Target Identification
      • 12.2.2. Precision/Personalized Medicine
      • 12.2.3. Population Genomics & Biobanking
      • 12.2.4. Rare Disease Research
      • 12.2.5. Oncology Genomics
      • 12.2.6. Agrigenomics & Crop Improvement
      • 12.2.7. Infectious Disease Genomic Surveillance
      • 12.2.8. Clinical Diagnostics & Reporting
      • 12.2.9. Other Applications
  • 13. Global Genomic Collaboration Market Analysis and Forecasts, by End-Users
    • 13.1. Key Findings
    • 13.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by End-Users, 2021-2035
      • 13.2.1. Pharmaceutical & Biotechnology Companies
      • 13.2.2. Academic & Research Institutions
      • 13.2.3. Hospitals & Diagnostic Laboratories
      • 13.2.4. Government & Public Health Agencies
      • 13.2.5. Contract Research Organizations (CROs)
      • 13.2.6. Agricultural & Agrotech Companies
      • 13.2.7. Other End-Users
  • 14. Global Genomic Collaboration Market Analysis and Forecasts, by Region
    • 14.1. Key Findings
    • 14.2. Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
      • 14.2.1. North America
      • 14.2.2. Europe
      • 14.2.3. Asia Pacific
      • 14.2.4. Middle East
      • 14.2.5. Africa
      • 14.2.6. South America
  • 15. North America Genomic Collaboration Market Analysis
    • 15.1. Key Segment Analysis
    • 15.2. Regional Snapshot
    • 15.3. North America Genomic Collaboration Market Size- Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 15.3.1. Collaboration Type
      • 15.3.2. Collaboration Model
      • 15.3.3. Genomic Data Type
      • 15.3.4. Platform
      • 15.3.5. Deployment Mode
      • 15.3.6. Organization Size
      • 15.3.7. Application
      • 15.3.8. End-Users
      • 15.3.9. Country
        • 15.3.9.1. USA
        • 15.3.9.2. Canada
        • 15.3.9.3. Mexico
    • 15.4. USA Genomic Collaboration Market
      • 15.4.1. Country Segmental Analysis
      • 15.4.2. Collaboration Type
      • 15.4.3. Collaboration Model
      • 15.4.4. Genomic Data Type
      • 15.4.5. Platform
      • 15.4.6. Deployment Mode
      • 15.4.7. Organization Size
      • 15.4.8. Application
      • 15.4.9. End-Users
    • 15.5. Canada Genomic Collaboration Market
      • 15.5.1. Country Segmental Analysis
      • 15.5.2. Collaboration Type
      • 15.5.3. Collaboration Model
      • 15.5.4. Genomic Data Type
      • 15.5.5. Platform
      • 15.5.6. Deployment Mode
      • 15.5.7. Organization Size
      • 15.5.8. Application
      • 15.5.9. End-Users
    • 15.6. Mexico Genomic Collaboration Market
      • 15.6.1. Country Segmental Analysis
      • 15.6.2. Collaboration Type
      • 15.6.3. Collaboration Model
      • 15.6.4. Genomic Data Type
      • 15.6.5. Platform
      • 15.6.6. Deployment Mode
      • 15.6.7. Organization Size
      • 15.6.8. Application
      • 15.6.9. End-Users
  • 16. Europe Genomic Collaboration Market Analysis
    • 16.1. Key Segment Analysis
    • 16.2. Regional Snapshot
    • 16.3. Europe Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 16.3.1. Collaboration Type
      • 16.3.2. Collaboration Model
      • 16.3.3. Genomic Data Type
      • 16.3.4. Platform
      • 16.3.5. Deployment Mode
      • 16.3.6. Organization Size
      • 16.3.7. Application
      • 16.3.8. End-Users
      • 16.3.9. Country
        • 16.3.9.1. Germany
        • 16.3.9.2. United Kingdom
        • 16.3.9.3. France
        • 16.3.9.4. Italy
        • 16.3.9.5. Spain
        • 16.3.9.6. Netherlands
        • 16.3.9.7. Nordic Countries
        • 16.3.9.8. Poland
        • 16.3.9.9. Russia & CIS
        • 16.3.9.10. Rest of Europe
    • 16.4. Germany Genomic Collaboration Market
      • 16.4.1. Country Segmental Analysis
      • 16.4.2. Collaboration Type
      • 16.4.3. Collaboration Model
      • 16.4.4. Genomic Data Type
      • 16.4.5. Platform
      • 16.4.6. Deployment Mode
      • 16.4.7. Organization Size
      • 16.4.8. Application
      • 16.4.9. End-Users
    • 16.5. United Kingdom Genomic Collaboration Market
      • 16.5.1. Country Segmental Analysis
      • 16.5.2. Collaboration Type
      • 16.5.3. Collaboration Model
      • 16.5.4. Genomic Data Type
      • 16.5.5. Platform
      • 16.5.6. Deployment Mode
      • 16.5.7. Organization Size
      • 16.5.8. Application
      • 16.5.9. End-Users
    • 16.6. France Genomic Collaboration Market
      • 16.6.1. Country Segmental Analysis
      • 16.6.2. Collaboration Type
      • 16.6.3. Collaboration Model
      • 16.6.4. Genomic Data Type
      • 16.6.5. Platform
      • 16.6.6. Deployment Mode
      • 16.6.7. Organization Size
      • 16.6.8. Application
      • 16.6.9. End-Users
    • 16.7. Italy Genomic Collaboration Market
      • 16.7.1. Country Segmental Analysis
      • 16.7.2. Collaboration Type
      • 16.7.3. Collaboration Model
      • 16.7.4. Genomic Data Type
      • 16.7.5. Platform
      • 16.7.6. Deployment Mode
      • 16.7.7. Organization Size
      • 16.7.8. Application
      • 16.7.9. End-Users
    • 16.8. Spain Genomic Collaboration Market
      • 16.8.1. Country Segmental Analysis
      • 16.8.2. Collaboration Type
      • 16.8.3. Collaboration Model
      • 16.8.4. Genomic Data Type
      • 16.8.5. Platform
      • 16.8.6. Deployment Mode
      • 16.8.7. Organization Size
      • 16.8.8. Application
      • 16.8.9. End-Users
    • 16.9. Netherlands Genomic Collaboration Market
      • 16.9.1. Country Segmental Analysis
      • 16.9.2. Collaboration Type
      • 16.9.3. Collaboration Model
      • 16.9.4. Genomic Data Type
      • 16.9.5. Platform
      • 16.9.6. Deployment Mode
      • 16.9.7. Organization Size
      • 16.9.8. Application
      • 16.9.9. End-Users
    • 16.10. Nordic Countries Genomic Collaboration Market
      • 16.10.1. Country Segmental Analysis
      • 16.10.2. Collaboration Type
      • 16.10.3. Collaboration Model
      • 16.10.4. Genomic Data Type
      • 16.10.5. Platform
      • 16.10.6. Deployment Mode
      • 16.10.7. Organization Size
      • 16.10.8. Application
      • 16.10.9. End-Users
    • 16.11. Poland Genomic Collaboration Market
      • 16.11.1. Country Segmental Analysis
      • 16.11.2. Collaboration Type
      • 16.11.3. Collaboration Model
      • 16.11.4. Genomic Data Type
      • 16.11.5. Platform
      • 16.11.6. Deployment Mode
      • 16.11.7. Organization Size
      • 16.11.8. Application
      • 16.11.9. End-Users
    • 16.12. Russia & CIS Genomic Collaboration Market
      • 16.12.1. Country Segmental Analysis
      • 16.12.2. Collaboration Type
      • 16.12.3. Collaboration Model
      • 16.12.4. Genomic Data Type
      • 16.12.5. Platform
      • 16.12.6. Deployment Mode
      • 16.12.7. Organization Size
      • 16.12.8. Application
      • 16.12.9. End-Users
    • 16.13. Rest of Europe Genomic Collaboration Market
      • 16.13.1. Country Segmental Analysis
      • 16.13.2. Collaboration Type
      • 16.13.3. Collaboration Model
      • 16.13.4. Genomic Data Type
      • 16.13.5. Platform
      • 16.13.6. Deployment Mode
      • 16.13.7. Organization Size
      • 16.13.8. Application
      • 16.13.9. End-Users
  • 17. Asia Pacific Genomic Collaboration Market Analysis
    • 17.1. Key Segment Analysis
    • 17.2. Regional Snapshot
    • 17.3. Asia Pacific Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 17.3.1. Collaboration Type
      • 17.3.2. Collaboration Model
      • 17.3.3. Genomic Data Type
      • 17.3.4. Platform
      • 17.3.5. Deployment Mode
      • 17.3.6. Organization Size
      • 17.3.7. Application
      • 17.3.8. End-Users
      • 17.3.9. Country
        • 17.3.9.1. China
        • 17.3.9.2. India
        • 17.3.9.3. Japan
        • 17.3.9.4. South Korea
        • 17.3.9.5. Australia and New Zealand
        • 17.3.9.6. Indonesia
        • 17.3.9.7. Malaysia
        • 17.3.9.8. Thailand
        • 17.3.9.9. Vietnam
        • 17.3.9.10. Rest of Asia Pacific
    • 17.4. China Genomic Collaboration Market
      • 17.4.1. Country Segmental Analysis
      • 17.4.2. Collaboration Type
      • 17.4.3. Collaboration Model
      • 17.4.4. Genomic Data Type
      • 17.4.5. Platform
      • 17.4.6. Deployment Mode
      • 17.4.7. Organization Size
      • 17.4.8. Application
      • 17.4.9. End-Users
    • 17.5. India Genomic Collaboration Market
      • 17.5.1. Country Segmental Analysis
      • 17.5.2. Collaboration Type
      • 17.5.3. Collaboration Model
      • 17.5.4. Genomic Data Type
      • 17.5.5. Platform
      • 17.5.6. Deployment Mode
      • 17.5.7. Organization Size
      • 17.5.8. Application
      • 17.5.9. End-Users
    • 17.6. Japan Genomic Collaboration Market
      • 17.6.1. Country Segmental Analysis
      • 17.6.2. Collaboration Type
      • 17.6.3. Collaboration Model
      • 17.6.4. Genomic Data Type
      • 17.6.5. Platform
      • 17.6.6. Deployment Mode
      • 17.6.7. Organization Size
      • 17.6.8. Application
      • 17.6.9. End-Users
    • 17.7. South Korea Genomic Collaboration Market
      • 17.7.1. Country Segmental Analysis
      • 17.7.2. Collaboration Type
      • 17.7.3. Collaboration Model
      • 17.7.4. Genomic Data Type
      • 17.7.5. Platform
      • 17.7.6. Deployment Mode
      • 17.7.7. Organization Size
      • 17.7.8. Application
      • 17.7.9. End-Users
    • 17.8. Australia and New Zealand Genomic Collaboration Market
      • 17.8.1. Country Segmental Analysis
      • 17.8.2. Collaboration Type
      • 17.8.3. Collaboration Model
      • 17.8.4. Genomic Data Type
      • 17.8.5. Platform
      • 17.8.6. Deployment Mode
      • 17.8.7. Organization Size
      • 17.8.8. Application
      • 17.8.9. End-Users
    • 17.9. Indonesia Genomic Collaboration Market
      • 17.9.1. Country Segmental Analysis
      • 17.9.2. Collaboration Type
      • 17.9.3. Collaboration Model
      • 17.9.4. Genomic Data Type
      • 17.9.5. Platform
      • 17.9.6. Deployment Mode
      • 17.9.7. Organization Size
      • 17.9.8. Application
      • 17.9.9. End-Users
    • 17.10. Malaysia Genomic Collaboration Market
      • 17.10.1. Country Segmental Analysis
      • 17.10.2. Collaboration Type
      • 17.10.3. Collaboration Model
      • 17.10.4. Genomic Data Type
      • 17.10.5. Platform
      • 17.10.6. Deployment Mode
      • 17.10.7. Organization Size
      • 17.10.8. Application
      • 17.10.9. End-Users
    • 17.11. Thailand Genomic Collaboration Market
      • 17.11.1. Country Segmental Analysis
      • 17.11.2. Collaboration Type
      • 17.11.3. Collaboration Model
      • 17.11.4. Genomic Data Type
      • 17.11.5. Platform
      • 17.11.6. Deployment Mode
      • 17.11.7. Organization Size
      • 17.11.8. Application
      • 17.11.9. End-Users
    • 17.12. Vietnam Genomic Collaboration Market
      • 17.12.1. Country Segmental Analysis
      • 17.12.2. Collaboration Type
      • 17.12.3. Collaboration Model
      • 17.12.4. Genomic Data Type
      • 17.12.5. Platform
      • 17.12.6. Deployment Mode
      • 17.12.7. Organization Size
      • 17.12.8. Application
      • 17.12.9. End-Users
    • 17.13. Rest of Asia Pacific Genomic Collaboration Market
      • 17.13.1. Country Segmental Analysis
      • 17.13.2. Collaboration Type
      • 17.13.3. Collaboration Model
      • 17.13.4. Genomic Data Type
      • 17.13.5. Platform
      • 17.13.6. Deployment Mode
      • 17.13.7. Organization Size
      • 17.13.8. Application
      • 17.13.9. End-Users
  • 18. Middle East Genomic Collaboration Market Analysis
    • 18.1. Key Segment Analysis
    • 18.2. Regional Snapshot
    • 18.3. Middle East Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 18.3.1. Collaboration Type
      • 18.3.2. Collaboration Model
      • 18.3.3. Genomic Data Type
      • 18.3.4. Platform
      • 18.3.5. Deployment Mode
      • 18.3.6. Organization Size
      • 18.3.7. Application
      • 18.3.8. End-Users
      • 18.3.9. Country
        • 18.3.9.1. Turkey
        • 18.3.9.2. UAE
        • 18.3.9.3. Saudi Arabia
        • 18.3.9.4. Israel
        • 18.3.9.5. Rest of Middle East
    • 18.4. Turkey Genomic Collaboration Market
      • 18.4.1. Country Segmental Analysis
      • 18.4.2. Collaboration Type
      • 18.4.3. Collaboration Model
      • 18.4.4. Genomic Data Type
      • 18.4.5. Platform
      • 18.4.6. Deployment Mode
      • 18.4.7. Organization Size
      • 18.4.8. Application
      • 18.4.9. End-Users
    • 18.5. UAE Genomic Collaboration Market
      • 18.5.1. Country Segmental Analysis
      • 18.5.2. Collaboration Type
      • 18.5.3. Collaboration Model
      • 18.5.4. Genomic Data Type
      • 18.5.5. Platform
      • 18.5.6. Deployment Mode
      • 18.5.7. Organization Size
      • 18.5.8. Application
      • 18.5.9. End-Users
    • 18.6. Saudi Arabia Genomic Collaboration Market
      • 18.6.1. Country Segmental Analysis
      • 18.6.2. Collaboration Type
      • 18.6.3. Collaboration Model
      • 18.6.4. Genomic Data Type
      • 18.6.5. Platform
      • 18.6.6. Deployment Mode
      • 18.6.7. Organization Size
      • 18.6.8. Application
      • 18.6.9. End-Users
    • 18.7. Israel Genomic Collaboration Market
      • 18.7.1. Country Segmental Analysis
      • 18.7.2. Collaboration Type
      • 18.7.3. Collaboration Model
      • 18.7.4. Genomic Data Type
      • 18.7.5. Platform
      • 18.7.6. Deployment Mode
      • 18.7.7. Organization Size
      • 18.7.8. Application
      • 18.7.9. End-Users
    • 18.8. Rest of Middle East Genomic Collaboration Market
      • 18.8.1. Country Segmental Analysis
      • 18.8.2. Collaboration Type
      • 18.8.3. Collaboration Model
      • 18.8.4. Genomic Data Type
      • 18.8.5. Platform
      • 18.8.6. Deployment Mode
      • 18.8.7. Organization Size
      • 18.8.8. Application
      • 18.8.9. End-Users
  • 19. Africa Genomic Collaboration Market Analysis
    • 19.1. Key Segment Analysis
    • 19.2. Regional Snapshot
    • 19.3. Africa Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 19.3.1. Collaboration Type
      • 19.3.2. Collaboration Model
      • 19.3.3. Genomic Data Type
      • 19.3.4. Platform
      • 19.3.5. Deployment Mode
      • 19.3.6. Organization Size
      • 19.3.7. Application
      • 19.3.8. End-Users
      • 19.3.9. Country
        • 19.3.9.1. South Africa
        • 19.3.9.2. Egypt
        • 19.3.9.3. Nigeria
        • 19.3.9.4. Algeria
        • 19.3.9.5. Rest of Africa
    • 19.4. South Africa Genomic Collaboration Market
      • 19.4.1. Country Segmental Analysis
      • 19.4.2. Collaboration Type
      • 19.4.3. Collaboration Model
      • 19.4.4. Genomic Data Type
      • 19.4.5. Platform
      • 19.4.6. Deployment Mode
      • 19.4.7. Organization Size
      • 19.4.8. Application
      • 19.4.9. End-Users
    • 19.5. Egypt Genomic Collaboration Market
      • 19.5.1. Country Segmental Analysis
      • 19.5.2. Collaboration Type
      • 19.5.3. Collaboration Model
      • 19.5.4. Genomic Data Type
      • 19.5.5. Platform
      • 19.5.6. Deployment Mode
      • 19.5.7. Organization Size
      • 19.5.8. Application
      • 19.5.9. End-Users
    • 19.6. Nigeria Genomic Collaboration Market
      • 19.6.1. Country Segmental Analysis
      • 19.6.2. Collaboration Type
      • 19.6.3. Collaboration Model
      • 19.6.4. Genomic Data Type
      • 19.6.5. Platform
      • 19.6.6. Deployment Mode
      • 19.6.7. Organization Size
      • 19.6.8. Application
      • 19.6.9. End-Users
    • 19.7. Algeria Genomic Collaboration Market
      • 19.7.1. Country Segmental Analysis
      • 19.7.2. Collaboration Type
      • 19.7.3. Collaboration Model
      • 19.7.4. Genomic Data Type
      • 19.7.5. Platform
      • 19.7.6. Deployment Mode
      • 19.7.7. Organization Size
      • 19.7.8. Application
      • 19.7.9. End-Users
    • 19.8. Rest of Africa Genomic Collaboration Market
      • 19.8.1. Country Segmental Analysis
      • 19.8.2. Collaboration Type
      • 19.8.3. Collaboration Model
      • 19.8.4. Genomic Data Type
      • 19.8.5. Platform
      • 19.8.6. Deployment Mode
      • 19.8.7. Organization Size
      • 19.8.8. Application
      • 19.8.9. End-Users
  • 20. South America Genomic Collaboration Market Analysis
    • 20.1. Key Segment Analysis
    • 20.2. Regional Snapshot
    • 20.3. South America Genomic Collaboration Market Size Value (US$ Bn), Analysis, and Forecasts, 2021-2035
      • 20.3.1. Collaboration Type
      • 20.3.2. Collaboration Model
      • 20.3.3. Genomic Data Type
      • 20.3.4. Platform
      • 20.3.5. Deployment Mode
      • 20.3.6. Organization Size
      • 20.3.7. Application
      • 20.3.8. End-Users
      • 20.3.9. Country
        • 20.3.9.1. Brazil
        • 20.3.9.2. Argentina
        • 20.3.9.3. Rest of South America
    • 20.4. Brazil Genomic Collaboration Market
      • 20.4.1. Country Segmental Analysis
      • 20.4.2. Collaboration Type
      • 20.4.3. Collaboration Model
      • 20.4.4. Genomic Data Type
      • 20.4.5. Platform
      • 20.4.6. Deployment Mode
      • 20.4.7. Organization Size
      • 20.4.8. Application
      • 20.4.9. End-Users
    • 20.5. Argentina Genomic Collaboration Market
      • 20.5.1. Country Segmental Analysis
      • 20.5.2. Collaboration Type
      • 20.5.3. Collaboration Model
      • 20.5.4. Genomic Data Type
      • 20.5.5. Platform
      • 20.5.6. Deployment Mode
      • 20.5.7. Organization Size
      • 20.5.8. Application
      • 20.5.9. End-Users
    • 20.6. Rest of South America Genomic Collaboration Market
      • 20.6.1. Country Segmental Analysis
      • 20.6.2. Collaboration Type
      • 20.6.3. Collaboration Model
      • 20.6.4. Genomic Data Type
      • 20.6.5. Platform
      • 20.6.6. Deployment Mode
      • 20.6.7. Organization Size
      • 20.6.8. Application
      • 20.6.9. End-Users
  • 21. Key Players/ Company Profile
    • 21.1. Broad Institute
      • 21.1.1. Company Details/ Overview
      • 21.1.2. Company Financials
      • 21.1.3. Key Customers and Competitors
      • 21.1.4. Business/ Industry Portfolio
      • 21.1.5. Product Portfolio/ Specification Details
      • 21.1.6. Pricing Data
      • 21.1.7. Strategic Overview
      • 21.1.8. Recent Developments
    • 21.2. DNAnexus
    • 21.3. Foundation Medicine, Inc.
    • 21.4. Genestack Ltd
    • 21.5. Genomenon, Inc.
    • 21.6. Genomics England
    • 21.7. Genomics4RD
    • 21.8. Illumina
    • 21.9. QIAGEN
    • 21.10. Regeneron Genetics Center
    • 21.11. Sema4 (GeneDx)
    • 21.12. Seven Bridges Genomics
    • 21.13. Sophia Genetics SA
    • 21.14. Thermo Fisher Scientific
    • 21.15. Other Key Players

 

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF
PRICING DETAILS
USD 4150
USD 5950
USD 7750
Related Report  
YOU MAY ALSO LIKE
Algae Protein Market by Source Type, Form, Protein Content, Production Method, Nature, Extraction Technology, Grade, End-Use Industry, and Geography
Alternative Protein Market by Source/Type, Form, Product Type, Processing Technology, Distribution Channel, Protein Content, End-users, and Geography
Astaxanthin Market by Source/Origin, Form, Grade/Purity Level, Concentration Level, Production Technology, End-users, Distribution Channel, Packaging Type, and Geography
Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation